Hu, Yue-Mei
16009  results:
Search for persons X
?
1

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
The Lancet Regional Health - Western Pacific.  34 (2023)  - p. 100731 , 2023
 
?
4

Efficacy, safety, and immunogenicity of an Escherichia coli..:

Zhao, Fang-Hui ; Wu, Ting ; Hu, Yue-Mei...
The Lancet Infectious Diseases.  22 (2022)  12 - p. 1756-1768 , 2022
 
?
5

Inflammation-related adverse reactions following vaccinatio..:

Zhuang, Chun-Lan ; Lin, Zhi-Jie ; Bi, Zhao-Feng...
Emerging Microbes & Infections.  10 (2021)  1 - p. 365-375 , 2021
 
?
6

Safety and immunogenicity of meningococcal (Groups A and C)..:

Zhu, Feng-Cai ; Hu, Yue-Mei ; Li, Ya-Nan..
Human Vaccines & Immunotherapeutics.  17 (2020)  3 - p. 919-926 , 2020
 
?
7

Immunogenicity noninferiority study of 2 doses and 3 doses ..:

Hu, Yue-Mei ; Guo, Meng ; Li, Chang-Gui...
Science China Life Sciences.  63 (2019)  4 - p. 582-591 , 2019
 
?
 
?
 
?
14

Novel ultrabright luminescent copper nanoclusters and appli..:

Huang, Qiu-Qin ; Hu, Mei-Yue ; Li, Yan-Li...
Chemical Communications.  57 (2021)  77 - p. 9890-9893 , 2021
 
?
15

Safety and immunogenicity of an Escherichia coli-produced 9..:

Chu, Kai ; Bi, Zhao-Feng ; Huang, Wei-Jin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240382/.  , 2023
 
1-15